Advertisement

International Ophthalmology

, Volume 17, Issue 4, pp 201–210 | Cite as

Ocular pharmacokinetics of tobramycin

A comparative radioimmunoassay and microbiological assay
  • Sanjiv Desai
Original Papers

Abstract

The ocular pharmacokinetics of tobramycin were studied in human and rabbit eyes following topical and subconjunctival administration in humans and following intravitreal administration in rabbit eyes. Each aqueous and vitreous sample was analysed by radioimmunoassay and microbiological assay. Topical instillation of 0.3% eyedrops by a loading dose schedule provided rapid penetration of the drug into the aqueous humour with a peak titre of 3.24 mg/1 (RIA) at 2-hour intervals and therapeutic levels up to 6 hours. A subconjunctivally administered standard dose of 20 mg/0.5 ml of the drug also showed rapid penetration in therapeutically effective concentration with a peak titre of 22.34 mg/1 (RIA) and 16.80 mg/1 (MBA) at 2-hour intervals and therapeutic levels of the drug remained up to 20 hours later. A study of vitreous clearance following the administration of a single intravitreal injection in rabbit eyes showed bioavailability of the drug at therapeutically effective levels for more than 72 hours. Mostly two, but sometimes only one sample at each time interval, were studied. Radioimmunoassay and microbiological assay results showed excellent correlation, with correlation coefficent > 0.90 at 1.0% level of probability.

Key words

aqueous penetration microbiological assay ocular kinetics radioimmunoassay toramycin vitreous clearance 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Christy NE, Lall P. Post operative endophthalmitis following cataract surgery: effects of subconjunctival antibiotic and other factors. Arch Ophthalmol 1973; 90: 361–6.Google Scholar
  2. 2.
    Carney M, Peyman GA. Vitrectomy in Endophthalmitis. Int Ophthalmol Clin 1987; 27:127–34.Google Scholar
  3. 3.
    Fisch A, Salvanet A, Prazuck T et al. Epidemiology of infective endophthalmitis in France. Lancet 1991; 338:1373–6.Google Scholar
  4. 4.
    Gilman AG, Rall TW, Nies AS, Tayler P, (eds). Goodman and Gilman's — the pharamacological basis of therapeutics, 8th edition, Vol 2. Pergamon Press, 1991; 1098–1102.Google Scholar
  5. 5.
    Leopold IH. Anti-infective agents. In: Sears MN (ed) ‘Pharmacology of the eye’. Springer, New York, pp 385–446, 1984.Google Scholar
  6. 6.
    Leopold IH. Update on antibiotics in ocular infections. Am J Ophthalmol 1985; 100:134–40.Google Scholar
  7. 7.
    D'Amico DJ, Caspers-Velu L, Libert J et al. Comparative toxicity of intravitreal aminoglycoside antibiotics. Am J Ophthalmol 1985; 100: 264–75.Google Scholar
  8. 8.
    Diestag J, Neu HC:In vitro studies of tobramycin, an aminoglycoside antibiotic: Antimicrob. Agents Chemother 1972; 1: 41–5.Google Scholar
  9. 9.
    Bodey C, Stewart D:In vitro studies of tobramycin: Antimicrob. Agents Chemother 1972; 2:109–13.Google Scholar
  10. 10.
    Lode H, Kammerich B, Koeppe P. Comparative clinical Pharmacology of Gentamicin, Sisomicin and Tobramycin: Antimicrob. Agents Chemother 1975; 8: 396–101.Google Scholar
  11. 11.
    Waitz JA, Moss EL, Drube CG, Weinstein MJ. Comparative activity of Sisomicin, Gentamicin, Kanamycin and Tobramycin: Antimicrob. Agents Chemother 1972; 2:431–7.Google Scholar
  12. 12.
    Traub WH, Raymond E. Evaluation of thein vitro activity of Tobramycin as compared with that of gentamicin sulphate. Appl Microbiol 1972; 23: 4–7.Google Scholar
  13. 13.
    Waterworth PM. Thein vitro activity of Tobramycin compared with that of other aminoglycosides. J Clin Pathol 1972; 25: 979–83.Google Scholar
  14. 14.
    Wingfield DL, McDougal EL, Roy FH, Hanna C. Ocular penetration of Amikacin following intramuscular injection. Arch Ophthalmol 1983; 101:117–20.Google Scholar
  15. 15.
    Crowe CC, Sanders E. Sisomicin evaluationin vitro and comparison with Gentamicin and tobramycin: Antimicrob. Agents Chemother 1973; 3: 24–8.Google Scholar
  16. 16.
    Preston DA, Wick WE. Preclinical assessment of antibacterial activity of nebramycin factor 6: Antimicrob. Agents Chemother 1972; 1: 239–42.Google Scholar
  17. 17.
    Smolin G. Okumoto M., Wilson F. The effect of tobramycin on gentamicin resistant strains in Pseudomonas Keratitis. Am J Ophthalmol 1974; 77: 583–8.Google Scholar
  18. 18.
    Laibson P, Smolin G, Rosenthal A et al. A clinical comparison of tobramycin and gentamicin sulphate in the treatment of Ocular infections. Am J Ophthalmol 1981; 92: 836–41.Google Scholar
  19. 19.
    Furgiuele FP, Smith JP, Baron JG. Tobramycin levels in human eyes. Am J Ophthalmol 1978; 85:121–3.Google Scholar
  20. 20.
    Petounis A, Papapanos G, Karageorgiou-Makrohimelaki C. Penetration of tobramycin sulphate into the human eye. Br. J Ophthalmol 1978; 62: 660–2.Google Scholar
  21. 21.
    Gorden TB, Cunningham RD. Tobramycin levels in aqueous humour after subconjunctival injection in humans. Am J Ophthalmol 1982; 93:107–10.Google Scholar
  22. 22.
    Peyman GA, Vastine DW, Raichand M. Symposium on postoperative endophthalmitis: Experimental aspects and their clinical application. Ophthalmology 1987; 85: 374–85.Google Scholar
  23. 23.
    White LO, Scammel LM, Reeves DS. Serum Aminoglyco side Assay by Enzyme Mediated Immunoassay (EMIT): Correlation with Radioimmunoassay, Fluroimmunoassay and Acetyltransferase and Microbiological Assays: Antimicrob. Agents Chemother 1981; 19:1064–6.Google Scholar
  24. 24.
    Broughton A, Strong JE, Pickering LK, Bodey GP. Radioimmunoassay of iodinated tobramycin: Antimicrob. Agents Chemother 1976; 10: 652–8.Google Scholar
  25. 25.
    Young P, Barza M, Kane A, Baum J. Radioactive and bioassay of intraocular antibiotics. Arch Ophthalmol 1979; 97: 717–20.Google Scholar
  26. 26.
    Mikkelson TJ, Sukhbir SC, Robinson JR. Altered bioavailability of drugs in the eye fluids and tissues. J Pharm Sci 1973; 62:1648–53.Google Scholar
  27. 27.
    Mikkelson TJ, Sukhbir SC, Robinson JR. Competitive inhibition of drug protein interaction in eye fluids and tissues. J Pharm Sci 1973; 62:1942–5.Google Scholar
  28. 28.
    Bennett TO, Peyman GA. Toxicity of intravitreal aminoglycoside in primates. Can J Ophthalmol 1974; 9: 475–9.Google Scholar
  29. 29.
    Grove DC, Randall WA. Assay methods of antibiotics: A laboratory manual (Antibiotics Monograph 2), Medical Encyclopaedia, New York, 1955.Google Scholar
  30. 30.
    Maurice DM. Factors influencing the penetration of topically applied drugs. Int Ophthalmol Clin 1980; 20: 21–32.Google Scholar
  31. 31.
    Sloan SH, Pettit TH, Litwack KD. Gentamicin penetration. Am J Ophthalmol 1972; 73: 750–3.Google Scholar
  32. 32.
    Baum J. Antibiotic mechanism. In: Smolin G, Thoft RA (eds) ‘The Corneal’ Brown and Co., 2nd edition, Boston, Little, pp 134–143, 1983.Google Scholar
  33. 33.
    Glasser DB, Gardner S, Ellis JG, Pettit TH. Loading doses and extended dosing intervals in topical gentamicin therapy. Am J Ophthalmol 1985; 99: 329–33.Google Scholar
  34. 34.
    Nelson P, Peyman GA, Benett TO. BB-K8: A aminoglycoside for intravitreal injection in bacterial endophthalmitis. Am J Ophthalmol 1974; 78: 82–5.Google Scholar
  35. 35.
    Furgiuele FP. Ocular penetration and tolerance of gentamicin. Am J Ophthalmol 1967; 64: 421–6.Google Scholar
  36. 36.
    Peyman GA, Sanders DR, Goldberg MF. Treatment of endophthalmitis. Advances in uveal surgery, vitreous surgery and the treatment of endophthalmitis. Appletonn-Century-Crofts, New York 1975:179–223.Google Scholar
  37. 37.
    Ellerhorst B, Golden B, Jarudi N. Ocular penetration of topically applied Gentamicin. Arch Ophthalmol 1975; 93: 371–8.Google Scholar
  38. 38.
    Insler MS, Helm CJ, George WJ. Topical versus systemic Gentamicin penetration into the human cornea and aqueous humor. Arch Ophthalmol 1987; 105: 922–4.Google Scholar
  39. 39.
    Methalone MBR, Harden A. Penetration and systemic absorption of gentamicin after subconjunctival injection. Br J Ophthalmol 1972; 55: 609–12.Google Scholar
  40. 40.
    Orr WM, Jackson WD, Golden K. Intraocular penetration of netilmicin. 1985; 20:171–5.Google Scholar
  41. 41.
    Barza M, Baum J, Kane A. Regional difference in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit. Am J Ophthalmol 1977; 83: 407–13.Google Scholar
  42. 42.
    Friend J. Biochemistry of ocular surface epithelium. Int Ophthalmol Clin 1979; 19: 73–91.Google Scholar
  43. 43.
    Golden B, Coppel SP. Ocular tissue absorption of gentamicin. Arch Ophthalmol 1970; 84: 792–5.Google Scholar
  44. 44.
    Kuming BS, Tonkin M. Use of gentamicin sulphate in ophthalmology (1). Absorption of gentamicin into the rabbit aqueous. Br J Ophthalmol 1974; 58: 609–12.Google Scholar
  45. 45.
    Uwaydah M, Faris BM. Penetration of tobramycin in the aqueous humor of the rabbit. Arch Ophthalmol 1976; 94: 117–314.Google Scholar
  46. 46.
    Richards AB, Bron AJ, Rice NSC, Fells P, Marshal MJ, Jones BR. Intraocular penetration of cephaloridine. Br J Ophthalmol 1972; 56: 531–6.Google Scholar
  47. 47.
    Eiferman RA, Stanger JI. Intraocular penetration of Amikacin. Arch Ophthalmol 1982; 100:1817–9.Google Scholar
  48. 48.
    Olson JC, Flynn HW Jr, Forster RK et al. Results in the treatment of postoperative endophthalmitis. Ophthalmology 1983; 90: 692–9.Google Scholar
  49. 49.
    Okumoto M. Laboratory diagnosis of endophthalmitis. Int Ophthalmol Clin 1987; 27: 89–94.Google Scholar
  50. 50.
    Bennett TO, Peyman GA. Use of tobramycin in eradicating experimental bacterial endophthalmitis. Graefes Clin Exp Ophthalmol 1974; 191: 93–107.Google Scholar
  51. 51.
    Briant MC. Antibiotics and their laboratory control. Butterworths, London 1972:1014.Google Scholar
  52. 52.
    Gulati V, Desai S, Joshi KR, Khatri PK. Aqueous penetration of orally administration Ciprofloxacin. ICMR Research Project, 1992, Unpublished data on file.Google Scholar
  53. 53.
    Behrens-Baumann W, Martell J. Ciprofloxacin concentrations in human aqueous humor following intravenous administration. Chemotherapy 1987; 33: 328–30.Google Scholar

Copyright information

© Kluwer Academic Publishers 1993

Authors and Affiliations

  • Sanjiv Desai
    • 1
  1. 1.Rupal Gajjar Low Vision CentreTarabai Eye HospitalRajasthanIndia

Personalised recommendations